A Possible Treatment for CDKL5 Deficiency Disorder has Earned Rare Pediatric Disease Designation
source: pixabay.com

A Possible Treatment for CDKL5 Deficiency Disorder has Earned Rare Pediatric Disease Designation

According to a story from BioSpace, the pharmaceutical company Marinus Pharmaceuticals, Inc. announced recently that its investigational product candidate ganaxolone has earned Rare Pediatric Disease designation from the US Food…

Continue Reading A Possible Treatment for CDKL5 Deficiency Disorder has Earned Rare Pediatric Disease Designation

The International Foundation For CDKL5 Research’s International CDKL5 Family Education and Awareness Conference

  • Post author:
  • Post category:

The 4th International Family Conference "UNITY FOR A CURE" This conference will be an opportunity for medical professionals, caregivers, and patient families to come together collaboratively to learn about the…

Continue Reading The International Foundation For CDKL5 Research’s International CDKL5 Family Education and Awareness Conference